Novel approaches to smoothing and comparing SELDI TOF spectra

Cancer Informatics

Volumn 1, Issue 1, 2007, Pages 78-85

  Meleth, Sreelatha ^a   Eltoum, Isam Eldin ^b   Zhu, Liu ^b   Oelschlager, Denise ^b   Piyathilake, Chandrika ^b   Chhieng, David ^b   Grizzle, William E ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AUC; Biomarkers; Denoising; Peaks; SELDI

Indexed keywords

EID: 35548969655     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510500100109     Document Type: Article

References (18)

1. Anderson NG., Matheson A, Anderson NL. Back to the future: the human protein index (HPI) and the agenda for post-proteomic biology. Proteomics, 2001, 1: 3-12.
2. Baggerly KA., Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics, 2004, 20: 777-85.
3. Baggerly KA., Morris JS, et al. A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples. Proteomics, 2003, 3: 1667-72.
4. Coombes KR., Fritsche HA Jr, Clarke C, et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surfaceenhanced laser desorption and ionization. Clin Chem, 2003, 49: 1615-23.
5. Diamandis EP. Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem, 2003, 49: 1272-5.
6. Draper NR., Smith H. Applied Regression Analysis, Second Edition, 1981, New York: John Wiley & Sons.
7. Dwek MV., Alaiya AA. Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues. Br J Cancer, 2003, 89: 305-7.
8. Lachenbruch PA., Goldstein M. Discriminant Analysis Biometrics, 1979, 35: 69-85.
9. Lee KR., Lin X, Park DC, et al. Megavariate data analysis of mass spectrometric proteomics data using latent variable projection method. Proteomics, 2003, 3: 1680-6.
10. Moreno L., Pineiro JD, Sanchez JL, et al. Brain maturation estimation using neural classifier. IEEE Trans Biomed Eng, 1995, 42: 428-32.
11. Petricoin EF., Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359: 572-7.
12. Qu Y., Adam BL, Yasui Y, et al. Boosted decision tree analysis of surfaceenhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clinical Chemistry, 2002, 48: 1835-43.
13. Rosty C., Christa L, et al. Identification of hepatocarcinoma-intestine-pancreas/ pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Research, 2002, 62: 1868-75.
14. Shiwa M., Nishimura Y, et al. Rapid discovery and identification of a tissuespecific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochemical & Biophysical Research Communications, 2003, 309: 18-25.
15. Wadsworth JT., Somers KD, Stack BC Jr, et al. Identification of patients with head and neck cancer using serum protein profiles. Archives of Otolaryngology--Head & Neck Surgery, 2004, 130: 98-104.
16. Weber G., Vinterbo S, Ohno-Machado L. Building an asynchronous web-based tool for machine learning classification. Proc AMIA Symp, 2002, 869-73.
17. Xiao XY., Tang Y, Wei XP, et al. A preliminary analysis of non-small cell lung cancer biomarkers in serum. Biomedical & Environmental Sciences, 2003, 16: 140-8.
18. Yasui Y., Pepe M, Thompson ML, et al. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics, 2003, 4: 449-63.